The vascular imaging systems market is expected to witness 5.7% CAGR during 2017 – 2023. Growing prevalence of cardiovascular diseases and cancer, increasing aging population, rising awareness about imaging techniques, technological advancements in vascular imaging systems and increasing healthcare expenditure are the key growth drivers for the market.
In terms of product, the market has been segmented into CT (computed tomography), MRI (magnetic resonance imaging), X-ray, Ultrasound, and Nuclear imaging (PET (positron emission tomography) and SPECT (single-photon emission computed tomography)). CT has been the largest segment in the vascular imaging systems market. CT procedures involve large amounts of radiation doses than the conventional X-ray imaging procedures. For instance, adult abdominal CT produces 10 move, neonatal abdominal CT produces 20 move as compared to lateral chest radiography, which only produces 0.15 move. According to the Conference of Radiation Control Program Directors, Inc. (CRCPD), around 62 million CT procedures are performed every year in the U.S., including 4 million CT procedures performed on children. With the increase in the number of CT procedures worldwide, the demand for vascular imaging systems for diagnosing vascular diseases also increases, which drives the growth of the market.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/vascular-imaging-systems-market/report-sample
Geographically, North America has been the largest vascular imaging systems market, where the U.S. has been the largest contributor to the regional market. Increasing awareness about imaging techniques has been driving the growth of the North American market. In Europe, Germany has been the largest contributor to the market, followed by the U.K. and France. Asia-Pacific market is expected to grow at the highest CAGR, during 2017 – 2023, owing to increasing prevalence of cancer and cardiovascular diseases.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=vascular-imaging-systems-market
Some of the key players in the cancer/tumor profiling market include Siemens AG, General Electric Company, Hitachi Ltd., and Koninklijke Philips N.V., Carestream Health, Inc., Hologic, Inc., Esaote S.P.A, Shimazdu Corporation, Canon Inc., Orthoscan, Inc., and Fujifilm Corporation.